Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034924.xml
Download PDF
Nuklearmedizin 2017; 56(03): N22-N23
DOI: 10.3413/Nukmed-0868-16-12
DOI: 10.3413/Nukmed-0868-16-12
Case report
Cancer vaccination causes prolonged FDG accumulation in subcutaneous tissue
Authors
Further Information
Publication History
received:
18 December 2016
accepted in revised form:
03 April 2017
Publication Date:
02 January 2018 (online)
-
References
- 1 Adjei AA. Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumours. Ann Oncol 2000; 11 (10) 1335-1341.
- 2 Aldarouish M, Wang C. Trends and advances in tumour immunology and lung cancer immunotherapy. J Exp Clin Cancer Res 2016; 35 (01) 157.
- 3 Burger IA, Husmann L, Hany TF. et al. Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine. Clin Nucl Med 2011; 36 (10) 848-853.
- 4 Chiou VL, Burotto M. Pseudoprogression and Immune-Related Response in Solid tumours. J Clin Oncol 2015; 33 (31) 3541-3543.
- 5 Georgoulias V, Douillard JY, Khayat D. et al. A multicenter randomized phase IIb efficacy study of Vx-001, a peptide-based cancer vaccine as maintenance treatment in advanced non-smallcell lung cancer: treatment rationale and protocol dynamics. Clin Lung Cancer 2013; 14 (04) 461-465.
- 6 Hoos A, Parmiani G, Hege K. et al. A clinical development paradigm for cancer vaccines and related biologics. J Immunother 2007; 30 (01) 1-15.
- 7 Liang F, Lore K. Local innate immune responses in the vaccine adjuvant-injected muscle. Clin Transl Immunology 2016; 5 (04) e74.
- 8 Nguyen T, Urban J, Kalinski P. Therapeutic cancer vaccines and combination immunotherapies involving vaccination. Immunotargets Ther 2014; 3: 135-150.
- 9 Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumour-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10 (06) 673-679.